Cardiomyocyte injury, measured by cardiac troponin T/I levels, and hemodynamic stress, assessed through BNP and N-terminal B-type natriuretic peptide (NTproBNP) levels, can occur in COVID-19, similar to other pneumonia cases. This evidence concerns the gene NPPB and COVID-19.